As more information is discovered, it is showing that
As more information is discovered, it is showing that Amarex was either grossly negligent or working directly against Cytodyn.
This information is blowing big holes in our detractors narratives. All of the BS, the shorts and the concerned shareholders have been posting for the last few months, are proving out to be lies.
Take comfort that you have invested in a treatment that will revolutionize modern medicine! Take comfort that our management has found solid footing in Dr. Chris Recknor and Dr. Nitya Ray. All we needed was someone capable, that believes in what they are doing as much as we believe in it!
18
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Growth Forecast for the IVD Reagents Market The global In Vitro Diagnostic (IVD) reagents market is on an impressive trajectory to reach nearly USD 55.3 billion by 2029. The demand for IVD reagents has surged, driven by numerous factors such as a rising prevalence of chronic and infectious diseases, alongside a growing emphasis on preventive healthcare. In 2022, the IVD...
Continue Reading
Exciting Growth at Cayuga Centers With New Board Members Cayuga Centers is thrilled to announce the welcoming of nine new members to its Board of Trustees. This addition of distinguished professionals promises to enhance the agency's leadership and the resources it employs to support children, youth, and families across the nation. Each of these new board members brings a...
Continue Reading
Elements Massage Celebrates National Skin Care Awareness Month As National Skin Care Awareness Month comes to an end, Elements Massage, the nation's leading massage therapy concept, is highlighting skincare and wellness. Innovative Skincare Services Elements Massage has introduced enhanced skincare services in collaboration with Sanitas Skincare. This partnership marks...
Continue Reading
Understanding Danaher's Stock Growth Danaher Corporation (NYSE: DHR) has consistently demonstrated robust performance in the stock market. With an average annual return of 13.82%, it has outpaced the market by 1.08% over the past decade. Currently, Danaher boasts a commendable market capitalization of $163.05 billion. Investment Insight: What If You Invested $100? Let’s...
Continue Reading
Matthew A. Cartwright Rejoins Munley Law as Of Counsel The six-term Congressman brings decades of legal expertise and legislative accomplishments back to the Pennsylvania personal injury law firm. MUNLEY Law is excited to announce the return of former U.S. Representative Matthew A. Cartwright as Of Counsel. Following a commendable 12 years in Congress, Cartwright brings a...
Continue Reading
